Tenaya Therapeutics, Inc. (TNYA) earnings
TNYA earnings moved a median of -2.57% by the close. Quarterly and annual TNYA reports and results, each read against the price at its own news timestamp. Back to the TNYA overview →
21 measured TNYA earnings events.
Where these TNYA earnings landedvs 21 measured TNYA earnings reactions
| Middle 50% of TNYA earnings reactions | -6.95% to +3.46% |
|---|---|
| Median reaction (to close) | -2.57% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 TNYA earnings events with a measured close landed between -6.95% and +3.46%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Tenaya Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.36% | -6.95% | |
| Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | -0.36% | -6.95% | |
| Form 10-Q Tenaya Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.00% | +3.46% | |
| Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -3.00% | +3.46% | |
| Form 10-K Tenaya Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +8.20% | +5.05% | |
| Form 10-Q Tenaya Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +11.57% | +18.18% | |
| Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +11.57% | +18.18% | |
| Form 10-Q Tenaya Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.85% | -2.47% | |
| Tenaya Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +2.85% | -2.47% | |
| Form 10-Q Tenaya Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.97% | -3.14% | |
| Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | -3.97% | -3.14% | |
| Form 10-K Tenaya Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -3.50% | -0.57% | |
| Form 10-Q Tenaya Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +6.36% | +6.84% | |
| Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | +6.36% | +6.84% | |
| Form 10-Q Tenaya Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +6.80% | -2.57% | |
| Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | +6.80% | -2.57% | |
| Form 10-Q Tenaya Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.31% | -7.41% | |
| Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | +1.31% | -7.41% | |
| Form 10-K Tenaya Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.42% | -5.23% | |
| Form 10-Q Tenaya Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -7.80% | |
| Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | +0.00% | -7.80% |
Keep exploring
More TNYA: analyst actions → · SEC filings → · TNYA overview →